Stoke Therapeutics (STOK) PT Raised to $22 at Needham, latest STK-001 'data put STOK in a strong position heading into regulatory discussions'
Tweet Send to a Friend
(Updated - March 26, 2024 7:11 AM EDT)
Needham analyst Joseph Stringer raised the price target on Stoke Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst Joseph Stringer raised the price target on Stoke Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
